These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 31512408)
1. USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells. Lu Q; Zhang FL; Lu DY; Shao ZM; Li DQ Cancer Med; 2019 Nov; 8(15):6730-6740. PubMed ID: 31512408 [TBL] [Abstract][Full Text] [Related]
2. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells. Lu Q; Lu D; Shao ZM; Li DQ Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267 [TBL] [Abstract][Full Text] [Related]
3. Non-canonical regulation of homologous recombination DNA repair by the USP9X deubiquitylase. O'Dea R; Santocanale C J Cell Sci; 2020 Feb; 133(3):. PubMed ID: 31964704 [TBL] [Abstract][Full Text] [Related]
4. Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies. Peterson LF; Sun H; Liu Y; Potu H; Kandarpa M; Ermann M; Courtney SM; Young M; Showalter HD; Sun D; Jakubowiak A; Malek SN; Talpaz M; Donato NJ Blood; 2015 Jun; 125(23):3588-97. PubMed ID: 25814533 [TBL] [Abstract][Full Text] [Related]
5. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Schwickart M; Huang X; Lill JR; Liu J; Ferrando R; French DM; Maecker H; O'Rourke K; Bazan F; Eastham-Anderson J; Yue P; Dornan D; Huang DC; Dixit VM Nature; 2010 Jan; 463(7277):103-7. PubMed ID: 20023629 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress. Akiyama H; Umezawa Y; Ishida S; Okada K; Nogami A; Miura O Cancer Lett; 2019 Jul; 453():84-94. PubMed ID: 30946869 [TBL] [Abstract][Full Text] [Related]
7. Deubiquitinase FAM/USP9X interacts with the E3 ubiquitin ligase SMURF1 protein and protects it from ligase activity-dependent self-degradation. Xie Y; Avello M; Schirle M; McWhinnie E; Feng Y; Bric-Furlong E; Wilson C; Nathans R; Zhang J; Kirschner MW; Huang SM; Cong F J Biol Chem; 2013 Feb; 288(5):2976-85. PubMed ID: 23184937 [TBL] [Abstract][Full Text] [Related]
8. A Novel BRCA1-Associated Protein-1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1-Mediated DNA Repair. Parrotta R; Okonska A; Ronner M; Weder W; Stahel R; Penengo L; Felley-Bosco E J Thorac Oncol; 2017 Aug; 12(8):1309-1319. PubMed ID: 28389374 [TBL] [Abstract][Full Text] [Related]
9. Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma. Cox JL; Wilder PJ; Wuebben EL; Ouellette MM; Hollingsworth MA; Rizzino A Cancer Biol Ther; 2014 Aug; 15(8):1042-52. PubMed ID: 24841553 [TBL] [Abstract][Full Text] [Related]
10. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells. Chen Z; Wang HW; Wang S; Fan L; Feng S; Cai X; Peng C; Wu X; Lu J; Chen D; Chen Y; Wu W; Lu D; Liu N; You Y; Wang H J Clin Invest; 2019 Apr; 129(5):2043-2055. PubMed ID: 30958800 [TBL] [Abstract][Full Text] [Related]
11. BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis. Salas-Lloret D; García-Rodríguez N; Soto-Hidalgo E; González-Vinceiro L; Espejo-Serrano C; Giebel L; Mateos-Martín ML; de Ru AH; van Veelen PA; Huertas P; Vertegaal ACO; González-Prieto R Nat Commun; 2024 May; 15(1):4292. PubMed ID: 38769345 [TBL] [Abstract][Full Text] [Related]
12. USP9X destabilizes pVHL and promotes cell proliferation. Zhang C; Peng Z; Zhu M; Wang P; Du X; Li X; Liu Y; Jin Y; McNutt MA; Yin Y Oncotarget; 2016 Sep; 7(37):60519-60534. PubMed ID: 27517496 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis. Liu Y; Xu X; Lin P; He Y; Zhang Y; Cao B; Zhang Z; Sethi G; Liu J; Zhou X; Mao X J Biol Chem; 2019 Mar; 294(12):4572-4582. PubMed ID: 30718275 [TBL] [Abstract][Full Text] [Related]
14. β-catenin is regulated by USP9x and mediates resistance to TRAIL-induced apoptosis in breast cancer. Ouyang W; Zhang S; Yang B; Yang C; Zhang J; Zhou F; Xie C Oncol Rep; 2016 Feb; 35(2):717-24. PubMed ID: 26717875 [TBL] [Abstract][Full Text] [Related]
15. Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. Chen X; Lu D; Gao J; Zhu H; Zhou Y; Gao D; Zhou H J Proteome Res; 2019 Jun; 18(6):2654-2665. PubMed ID: 31059266 [TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair. Yu H; Pak H; Hammond-Martel I; Ghram M; Rodrigue A; Daou S; Barbour H; Corbeil L; Hébert J; Drobetsky E; Masson JY; Di Noia JM; Affar el B Proc Natl Acad Sci U S A; 2014 Jan; 111(1):285-90. PubMed ID: 24347639 [TBL] [Abstract][Full Text] [Related]
17. RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence. Haynes B; Gajan A; Nangia-Makker P; Shekhar MP Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165561. PubMed ID: 31639439 [TBL] [Abstract][Full Text] [Related]
18. USP7 deubiquitinase promotes ubiquitin-dependent DNA damage signaling by stabilizing RNF168. Zhu Q; Sharma N; He J; Wani G; Wani AA Cell Cycle; 2015; 14(9):1413-25. PubMed ID: 25894431 [TBL] [Abstract][Full Text] [Related]
19. Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance. Anantha RW; Simhadri S; Foo TK; Miao S; Liu J; Shen Z; Ganesan S; Xia B Elife; 2017 Apr; 6():. PubMed ID: 28398198 [TBL] [Abstract][Full Text] [Related]
20. USP9X regulates the proliferation, survival, migration and invasion of gastric cancer cells by stabilizing MTH1. Xu W; Zhang Y; Su Y; Li L; Yang X; Wang L; Gao H BMC Gastroenterol; 2024 Jul; 24(1):239. PubMed ID: 39075342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]